Adalvo Ltd. Pharmadox Healthcare Limited Qualimetrix S.A. Teva Operations Poland Sp. z o.o.
PolandAll drugs from this manufacturer
-
The medicine is used for the treatment of idiopathic pulmonary fibrosis (IPF) in adults, other chronic fibrosing interstitial lung diseases in adults, as well as in children and adolescents (from 6 to 17 years of age). It is also used for the treatment of interstitial lung disease associated with systemic sclerosis in adults, adolescents, and children over 6 years of age.
Dosage form: capsules, soft gelatin
Active substance Dosage nintedanib 100 mg ATC: L01EX09
-
The medicine is used for the treatment of idiopathic pulmonary fibrosis in adults, other chronic fibrosing interstitial lung diseases in adults, as well as in children and adolescents aged 6 to 17 years. It is also used in the treatment of interstitial lung disease associated with systemic sclerosis.
Dosage form: capsules, soft gelatin
Active substance Dosage nintedanib 150 mg ATC: L01EX09